Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.03% |
| 4 | Financials | 0.75% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
PUT
CVR Partners
UAN
$1.32B
| $5.42M | ﹤0.01% |
71,700
+17,700
| +33% | +$1.41M |
|
3277
Vanguard Ultra-Short Bond ETF
VUSB
$9.34B
| $5.42M | ﹤0.01% |
109,544
+86,414
| +374% | +$4.27M |
|
3278
Neurocrine Biosciences
NBIX
$15.7B
| $5.42M | ﹤0.01% |
39,398
+1,424
| +4% | +$195K |
|
3279
CALL
Vanguard Financials ETF
VFH
$13.9B
| $5.42M | ﹤0.01% |
54,300
-6,400
| -11% | -$639K |
|
|
IRBT
3280
PUT
DELISTED
iRobot
IRBT
| $5.42M | ﹤0.01% |
595,200
-480,700
| -45% | -$4.43M |
|
|
STR
3281
CALL
DELISTED
Sitio Royalties
STR
| $5.42M | ﹤0.01% |
229,500
-83,300
| -27% | -$1.96M |
|
3282
PUT
iShares Russell 2000 Growth ETF
IWO
$14.8B
| $5.41M | ﹤0.01% |
20,600
-600
| -3% | -$156K |
|
3283
CALL
iRhythm Holdings
IRTC
$3.96B
| $5.4M | ﹤0.01% |
50,200
-14,300
| -22% | -$1.46M |
|
3284
PUT
Burford Capital
BUR
$957M
| $5.4M | ﹤0.01% |
414,000
+122,500
| +42% | +$1.8M |
|
3285
iShares ESG Optimized MSCI USA ETF
SUSA
$4.14B
| $5.4M | ﹤0.01% |
48,068
+27,884
| +138% | +$3.02M |
|
3286
Kosmos Energy
KOS
$1.64B
| $5.39M | ﹤0.01% |
973,464
+489,969
| +101% | +$2.86M |
|
|
ESGR
3287
DELISTED
Enstar Group
ESGR
| $5.39M | ﹤0.01% |
17,637
+11,499
| +187% | +$3.45M |
|
3288
NexGen Energy
NXE
$6.97B
| $5.39M | ﹤0.01% |
772,416
+367,864
| +91% | +$2.82M |
|
3289
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.34B
| $5.39M | ﹤0.01% |
56,921
+33,518
| +143% | +$3.16M |
|
|
SWTX
3290
DELISTED
SpringWorks Therapeutics
SWTX
| $5.38M | ﹤0.01% |
142,717
-95,828
| -40% | -$4.03M |
|
|
OKLO
3291
CALL
Oklo
OKLO
$7.47B
| $5.37M | ﹤0.01% |
634,400
+542,700
| +592% | +$6.11M |
|
3292
Ventas
VTR
$47.1B
| $5.37M | ﹤0.01% |
104,812
-39,459
| -27% | -$1.85M |
|
3293
CALL
Autoliv
ALV
$8.94B
| $5.37M | ﹤0.01% |
50,200
-1,800
| -3% | -$214K |
|
|
CHX
3294
DELISTED
ChampionX
CHX
| $5.36M | ﹤0.01% |
161,323
+147,806
| +1,093% | +$5.04M |
|
3295
Acadia Pharmaceuticals
ACAD
$5.02B
| $5.36M | ﹤0.01% |
329,568
+156,465
| +90% | +$2.53M |
|
3296
Schwab International Dividend Equity ETF
SCHY
$2.55B
| $5.35M | ﹤0.01% |
+227,130
| New | +$5.47M |
|
3297
Steris
STE
$22.8B
| $5.35M | ﹤0.01% |
24,360
-1,359
| -5% | -$295K |
|
3298
PUT
Yum China
YUMC
$15.3B
| $5.35M | ﹤0.01% |
173,400
-144,800
| -46% | -$5.3M |
|
3299
Rithm Capital
RITM
$5.63B
| $5.34M | ﹤0.01% |
489,637
+343,563
| +235% | +$3.8M |
|
3300
CALL
Boise Cascade
BCC
$2.75B
| $5.34M | ﹤0.01% |
44,800
-9,900
| -18% | -$1.34M |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2024 filing shows 1,591 new, 4,593 increased, 5,607 reduced and 1,726 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M. The largest sale was NVIDIA, an estimated $5.31B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.